Kamen and Sequel Medtech CEO Alan Lotvin say they are offering greater precision in insulin delivery with new pump technology ...

This all-encompassing guide investigates the smart insulin pen and its influence on diabetes management. Here's what you need ...

CHICAGO - A Chicago woman with uncontrollable diabetes is now off insulin thanks to doctors at the University of Chicago. She ...

Insulclock CAP, which received EU approval in 2018, assists users in detecting and avoiding errors in insulin administration.

The grant will aid in carrying out laparoscopic surgical electrode implantation approaches and studies in a porcine model.

Eli Lilly has unveiled a new partnership with diabetes device maker Dexcom to breathe new life into its diabetes division. The deal will see Dexcom's continuous glucose monitors integrated into ...

NovoPen ®, the first insulin pen injector, was introduced in 1985. This article reviews the published evidence over two decades of use of the NovoPen ® family of injection devices in diabetes ...

“Notably, glucose values vary over a narrow range (from approximately 2 to 20-30 mM [36 mg/dL to 360-540 mg/dL] in people with diabetes), so a rather steep change in insulin bioactivity must be ...

Dr. Marion has assembled a team of high-profile, experienced pharmaceutical executives, former senior FDA members, and academic scientists to lead the development of PATAS. He has also established ...

Some diabetes patients this year have had trouble finding their preferred insulin brands as major drug manufacturers reported shortages of the medicine. USA TODAY set out to find out what patients ...

These findings may usher in a new era in diabetes treatment without the need for constant blood glucose monitoring, and insulin dosage comprises the foremost shortcomings of present therapies.

Vienna — Participants with type 2 diabetes who were able to stop insulin for up to 12 months after receiving the novel recellularization via electroporation therapy (ReCET) procedure in ...